Cronos Group has seen its stock price rise by over 70% over the last six months. While the rally has largely been driven by legalization in Canada and deal-making activity in the industry, Cronos' bread-and-butter medical marijuana business is likely to remain a crucial driver for the company.
Cronos Group has seen its stock price rise by over 70% over the last six months. While the rally has largely been driven by legalization in Canada and deal-making activity in the industry, Cronos' bread-and-butter medical marijuana business is likely to remain a crucial driver for the company.
Share this Article
Recommended